NVTA Invitae Corp

Invitae Corp is a genetic information company engaged in genetic diagnostics for hereditary disorders. It provides testing for multiple genes including hereditary cancer, neurological disorders, cardiovascular disorders and other hereditary conditions.

$2.54  +0.10 (4.10%)
As of 07/01/2022 16:00:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2015
Outstanding shares:  229,288,596
Average volume:  11,119,038
Market cap:   $559,464,174
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BVVCNT1
Valuation   (See tab for details)
PE ratio:   -0.82
PB ratio:   0.20
PS ratio:   1.16
Return on equity:   -15.87%
Net income %:   -93.93%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy